HALO logo

Halozyme Therapeutics, Inc. (HALO) P/E Ratio

PE Ratio:

13.22-0.09(-0.68%)
December 8, 2025

Summary

  • As of today, HALO price to earnings ratio is 13.22, with a fall of -0.09 (-0.68%) during the most recent trading session on December 8, 2025.
  • Over the past year, HALO PE ratio has dropped by -3.01 (-18.55%).
  • HALO PE ratio is now -95.35% below its all-time high of 284.35.

Performance

HALO PE Ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherHALOvaluation metrics

PE Ratio Formula

P/E =  
Price
TTM Earnings Per Share

HALO PE Ratio Trends

PeriodPeriodPE RatioPE RatioPricePriceTTM EPSTTM EPSTTM RevenueTTM Revenue
1D1 Day-0.7%-0.7%+8.7%+5.5%
1M1 Month-7.8%-7.8%--
3M3 Months-23.9%-17.3%+8.7%+5.5%
6M6 Months-8.4%+15.6%--
YTDYTD-5.1%+31.5%--
1Y1 Year-18.6%+28.2%+57.4%+31.2%
5Y5 Years-94.9%+59.1%+3001.3%+522.8%

HALO PE Ratio Highs & Lows

PeriodPeriodHighHighCurrent vs Highvs HighLowLowCurrent vs Lowvs Low
1M1-Month15.55-15.0%13.22at low
3M3-Month17.88-26.1%13.22at low
6M6-Month17.88-26.1%11.88+11.3%
1Y1-Year18.98-30.4%11.88+11.3%
3Y3-Year39.55-66.6%11.88+11.3%
5Y5-Year284.35-95.3%11.41+15.9%
All-TimeAll-Time284.35-95.3%11.41+15.9%

HALO PE Ratio History

DateValue
2025
13.22(-5.1%)
2024
13.93(-20.5%)
2023
17.52(-55.6%)
DateValue
2022
39.42(+169.3%)
2021
14.64(-69.1%)
2020
47.38(-11.1%)
2017
53.32

FAQ

  • What is Halozyme Therapeutics, Inc. price to earnings ratio?
  • What is the all-time high PE ratio for Halozyme Therapeutics, Inc.?
  • What is HALO price to earnings ratio year-to-date change?
  • What is Halozyme Therapeutics, Inc. PE ratio year-on-year change?

What is Halozyme Therapeutics, Inc. price to earnings ratio?

The current PE ratio of HALO is 13.22

What is the all-time high PE ratio for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high price to earnings ratio is 284.35

What is HALO price to earnings ratio year-to-date change?

Halozyme Therapeutics, Inc. price to earnings ratio has changed by -0.71 (-5.10%) since the beginning of the year

What is Halozyme Therapeutics, Inc. PE ratio year-on-year change?

Over the past year, HALO price to earnings ratio has changed by -3.01 (-18.55%)
On this page